Descriptor English: | Nitric Oxide | ||||
Descriptor Spanish: |
Óxido Nítrico
| ||||
Descriptor Portuguese: | Óxido Nítrico | ||||
Descriptor French: | Monoxyde d'azote | ||||
Entry term(s): |
Endogenous Nitrate Vasodilator Endothelium-Derived Nitric Oxide Mononitrogen Monoxide Monoxide, Mononitrogen Monoxide, Nitrogen Nitrate Vasodilator, Endogenous Nitric Oxide, Endothelium Derived Nitric Oxide, Endothelium-Derived Nitrogen Monoxide Oxide, Nitric Vasodilator, Endogenous Nitrate |
||||
Tree number(s): |
D01.339.409.500 D01.625.550.500 D01.625.700.500 D01.650.550.587.600 D02.389.508.500 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D009569 | ||||
Scope note: | A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Bronchodilator Agents Free Radical Scavengers Neurotransmitter Agents Endothelium-Dependent Relaxing Factors Gasotransmitters |
||||
Registry Number: | 31C4KY9ESH | ||||
CAS Type 1 Name: | Nitrogen oxide (NO) | ||||
Public MeSH Note: | 1965 |
||||
History Note: | 1965 |
||||
Related: |
Endothelium-Dependent Relaxing Factors
MeSH Nitric Oxide Donors MeSH | ||||
DeCS ID: | 9753 | ||||
Unique ID: | D009569 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1965/01/01 | ||||
Date of Entry: | 1999/01/01 | ||||
Revision Date: | 2013/07/08 |
-
-
CHEMICALS AND DRUGS
Inorganic Chemicals [D01]Inorganic Chemicals -
CHEMICALS AND DRUGS
Inorganic Chemicals [D01]Inorganic Chemicals -
CHEMICALS AND DRUGS
Inorganic Chemicals [D01]Inorganic Chemicals -
CHEMICALS AND DRUGS
Inorganic Chemicals [D01]Inorganic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals
|
Nitric Oxide
- Preferred
Concept UI |
M0014877 |
Scope note | A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. |
Preferred term | Nitric Oxide |
Entry term(s) |
Endogenous Nitrate Vasodilator Endothelium-Derived Nitric Oxide Mononitrogen Monoxide Monoxide, Mononitrogen Monoxide, Nitrogen Nitrate Vasodilator, Endogenous Nitric Oxide, Endothelium Derived Nitric Oxide, Endothelium-Derived Nitrogen Monoxide Oxide, Nitric Vasodilator, Endogenous Nitrate |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey